MANUFACTURING

Astellas and YASKAWA to establish joint venture focused on cell therapy manufacturing

Astellas Pharma and YASKAWA Electric Corporation have signed a definitive agreement to establish a joint venture for the development of a cell therapy product manufacturing platform utilizing the dual-arm...

View the Online Magazine

Latest Issue

Magazine Archive

Launches

Ultra-Hygienic mixing at small-scale

Introducing the new 150 UHS Ultra-Hygienic Small-Scale In-Line mixer from Silverson Machines. The 150 UHS In-Line is designed for Ultra Hygienic applications typically encountered in...

Pioneer Group drives AI innovation in healthcare through industry and academic collaboration

Pioneer Group, the life science infrastructure and venture building specialist, has joined forces with Innovate UK, The Medical Research Council (MRC) and AstraZeneca, to...

New SWLP laboratory at Croydon Hospital transforms the diagnostic facility into one of the most advanced and innovative in the UK

South West London Pathology (SWLP) introduces cutting-edge technologies to its laboratories to create one of the most modern, innovative, and efficient clinical blood science...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

Pharmanovia signs exclusive distribution agreement with Er-Kim for Sunosi in Eastern Europe

Pharmanovia has signed an exclusive distribution agreement with Er-Kim, to enhance the availability of Sunosi (Solriamfetol), a first-in-class treatment for Excessive Daytime Sleepiness (EDS),...

Dr. Reddy’s enters into collaboration with Henlius for commercialization of HLX15, a biosimilar candidate to Darzalex & Darzalex Faspro in the U.S. and Europe

Dr. Reddy’s Laboratories has entered into a license agreement with Shanghai Henlius Biotech for the commercialization of HLX15, Henlius’ investigational daratumumab biosimilar candidate to...

Er-Kim signs distribution agreement with the MEDICE Health Family for Vafseo in Central & Eastern Europe

Er-Kim, an international company specializing in the commercialization of novel therapies for pharmaceutical and biopharmaceutical companies, has signed a distribution agreement with the MEDICE...

Er-Kim extends exclusive distribution agreement with Ascendis to expand commercialization of endocrinology portfolio

Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies, has extended its exclusive agreement with Danish biopharmaceutical company Ascendis Pharma to commercialize...

Approvals

FDA approves Genentech’s TNKase in acute ischemic stroke

The U.S. Food and Drug Administration (FDA) has approved Genentech's TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke...

Celltrion receives EC approval for Avtozma, a biosimilar to RoActemra

The European Commission (EC) has granted marketing authorization for Celltrion's  Avtozma (CT-P47), a biosimilar referencing RoActemra (tocilizumab). Avtozma has been approved for all indications of its...

Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma

Mirum’s CTEXLI tablets receives FDA approval for cerebrotendinous xanthomatosis

Bavarian Nordic’s Chikungunya vaccine receives U.S. FDA approval for those aged 12 and older

European Commission approves CSL’s ANDEMBRY for the prevention of recurrent attacks of hereditary angioedema

Manufacturiung

Finance

Research & Development
Latest

R&D

Magnet Biomedicine and Lilly to develop novel molecular glue medicines

Magnet Biomedicine, a biopharmaceutical company advancing molecular glue discovery with rational selection and design, has entered a collaboration and license agreement with Eli Lilly...
R&D

Bioxodes secures Orphan Drug Designation for hemorrhagic stroke therapeutic candidate in US and Europe

Bioxodes, a clinical stage biopharmaceutical company developing novel therapies for the prevention and treatment of thrombotic and inflammatory diseases, has received Orphan Drug Designation...
R&D

Medigene and EpimAb Biotherapeutics to develop TCR-guided T Cell Engagers

Medigene and EpimAb Biotherapeutics have entered a strategic co-development agreement to research and develop off-the-shelf T cell receptor (TCR)-guided T Cell Engagers (TCR-TCEs) for...
R&D

Pyxis Oncology granted FDA Fast Track Designation for PYX-201 monotherapy in patients with recurrent or metastatic head and neck cancer

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Pyxis Oncology's PYX-201 for the treatment of adult patients with recurrent...
R&D

BridGene Biosciences and Takeda to discover small molecule drugs for immunology and neurology targets

BridGene Biosciences, which discovers small molecule drugs for traditionally “hard-to-drug” targets, has formed a strategic collaboration and licensing agreement with Takeda. Under the terms...

Appointments

© 2021 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks